FDA Issues Statement on Efforts to Increase Transparency in Medical Device Reporting

Posted By American Med Spa Association, Tuesday, June 25, 2019

In the spirit of promoting public transparency, the U.S. Food and Drug Administration’s Center for Devices and Radiological Health is taking a number of important steps to update its Medical Device Reporting (MDR) Program, one of the tools the FDA uses to monitor device performance, detect potential device-related safety concerns or signals and contribute to the benefit-risk assessment of these products.

Read more at FDA.gov >>